INSULIN HUMAN and MALAISE

Overview

MALAISE is the #11 most commonly reported adverse reaction for INSULIN HUMAN, manufactured by Eli Lilly and Company. There are 1,177 FDA adverse event reports linking INSULIN HUMAN to MALAISE. This represents approximately 1.4% of all 82,903 adverse event reports for this drug.

Patients taking INSULIN HUMAN who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

MALAISE is a less commonly reported adverse event for INSULIN HUMAN, but still significant enough to appear in the safety profile.

Other Side Effects of INSULIN HUMAN

In addition to malaise, the following adverse reactions have been reported for INSULIN HUMAN:

• BLOOD GLUCOSE INCREASED — 10,559 reports
• BLOOD GLUCOSE DECREASED — 3,452 reports
• DRUG INEFFECTIVE — 3,143 reports
• INCORRECT DOSE ADMINISTERED — 2,163 reports
• HYPOGLYCAEMIA — 1,533 reports
• NAUSEA — 1,469 reports
• VISUAL IMPAIRMENT — 1,463 reports
• WEIGHT DECREASED — 1,306 reports
• DYSPNOEA — 1,273 reports
• FALL — 1,243 reports

Other Drugs Associated with MALAISE

The following drugs have also been linked to malaise in FDA adverse event reports:

Does INSULIN HUMAN cause MALAISE?

MALAISE has been reported as an adverse event in 1,177 FDA reports for INSULIN HUMAN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is MALAISE with INSULIN HUMAN?

MALAISE accounts for approximately 1.4% of all adverse event reports for INSULIN HUMAN, making it a notable side effect.

What should I do if I experience MALAISE while taking INSULIN HUMAN?

If you experience malaise while taking INSULIN HUMAN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages